Starna Therapeutics

Pioneering Extrahepatic RNA Delivery

Suzhou, China · Founded 2021 · $106.1M raised

Headquarters
Suzhou
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$106.1M
Last Round
$40.0M Series BJan 2026
Rounds
4

About

Starna Therapeutics is a Suzhou, China-based biotechnology company founded in August 2021, focused on pioneering extrahepatic RNA delivery technologies using proprietary lipid nanoparticle (LNP) platforms. The company's tissue-specific LNPs (tsLNPs) and cell-selective LNPs (csLNPs) overcome the conventional limitation of LNPs accumulating in the liver, enabling RNA medicines to reach non-hepatic tissues with precision. Starna's pipeline includes in vivo CAR-T programs for autoimmune diseases, RSV and GBM vaccine candidates, and has raised over RMB 300 million in Series B funding co-led by LYFE Capital, Hillhouse Capital, and Lilly Asia Ventures.

Summary

Starna Therapeutics is a Biotech company based in Suzhou, China, founded in 2021. It has raised $106.1M in total across 4 rounds, most recently a $40.0M Series B round in Jan 2026. Investors include Source Code Capital, Tencent and LYFE Capital.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries B+Jan 2026
$40.0M

Sign up to see all 4 rounds

Angel through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Starna Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/starna-therapeutics"><img src="https://indexed.vc/api/badge/company/starna-therapeutics" alt="Starna Therapeutics on Indexed.vc" width="260" height="76" /></a>